Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer

被引:1
作者
Tsukioka, Takuma [1 ]
Izumi, Nobuhiro [1 ]
Mizuguchi, Shinjiro [1 ]
Kyukwang, Chung [1 ]
Komatsu, Hiroaki [1 ]
Toda, Michihito [1 ]
Hara, Kantaro [1 ]
Miyamoto, Hikaru [1 ]
Nishiyama, Noritoshi [1 ]
机构
[1] Osaka City Univ Hosp, Dept Thorac Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan
关键词
Non-small cell lung cancer; Multiple malignancies; Treatment interval; Prognostic factor; RECURRENCE; CARCINOMA; SURVIVAL; LESS;
D O I
10.1007/s10147-017-1185-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because most patients with small-sized non-small cell lung cancer (NSCLC) are asymptomatic, their lesions are detected by cancer screenings or routine checkups for other diseases. Incidences of multiple malignancies have been reported to be 27% in patients with stage I-III NSCLC. Some patients have treatment histories for other malignancies, and their small-sized NSCLC was incidentally detected during follow-up. There is no established report regarding the influence of multiple malignancies on small-sized NSCLC prognosis. Therefore, we investigated the correlation between multiple malignancies and surgical outcomes in patients with small-sized NSCLC. In total, 44 patients underwent definitive pulmonary resection for NSCLC of 1 cm or smaller between January 2003 and December 2012. Tumor size was measured by macroscopic findings of the resected specimens, and we then retrospectively investigated their clinical courses. One patient had hemoptysis symptoms, whereas 43 patients were asymptomatic; among them, NSCLC was detected by examinations for other diseases in 31 patients and by cancer screening in 12 patients. In total, 20 patients (45%) had multiple malignancies. The median follow-up period was 68 months. One patient had a recurrence from current NSCLC. No patients died of current NSCLC. The overall 5-year survival rate was 90% for all patients. Patients with multiple malignancies had significantly poorer prognoses compared with those without multiple malignancies (P = 0.016). However, patients with treatment intervals of more than 5 years had prognoses equivalent to those of patients without multiple malignancies (P = 0.829). Only the presence of multiple malignancies was a significantly poor prognostic factor in univariate and multivariate analyses. NSCLC of 1 cm or smaller showed good prognoses. The presence of multiple malignancies was a significantly poor prognostic factor, and short treatment intervals also correlated with poor prognosis.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [31] The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer
    Holgersson, Georg
    Bergqvist, Michael
    Nyman, Jan
    Hoye, Even
    Helsing, Martin
    Friesland, Signe
    Holgersson, Margareta
    Ekberg, Lars
    Morth, Charlotte
    Ekman, Simon
    Blystad, Thomas
    Ewers, Sven-Borje
    Loden, Britta
    Henriksson, Roger
    Bergstrom, Stefan
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [32] Surgical Treatment Outcomes of Patients with Non-Small Cell Lung Cancer and Lymph Node Metastases
    Shimizu, Yuki
    Koike, Terumoto
    Hasebe, Toshiki
    Nakamura, Masaya
    Goto, Tatsuya
    Toyabe, Shin-ichi
    Tsuchida, Masanori
    CANCERS, 2023, 15 (12)
  • [33] Outcomes of surgical treatment for isolated adrenal metastasis from non-small cell lung cancer
    Buero, Agustin
    Nardi, Walter S.
    Chimondeguy, Domingo J.
    Pankl, Leonardo G.
    Lyons, Gustavo A.
    Arboit, David Gonzalez
    Quildrian, Sergio
    ECANCERMEDICALSCIENCE, 2021, 15
  • [34] Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
    Kim, Sang Young
    Hong, Chang Ki
    Kim, Tae Hoon
    Hong, Je Beom
    Park, Chul Hwan
    Chang, Yoon Soo
    Kim, Hyung Jung
    Ahn, Chul Min
    Byun, Min Kwang
    YONSEI MEDICAL JOURNAL, 2015, 56 (01) : 103 - 111
  • [35] Impact of anesthetic factors on prognosis of patients with non-small cell lung cancer after surgery
    Zhu, Wenzhi
    Li, Shuang
    Ji, Xinqiang
    Tan, Hongyu
    JOURNAL OF THORACIC DISEASE, 2023, 15 (09) : 4869 - 4884
  • [36] Surgical outcomes of segmental bronchial sleeve resection in central non-small cell lung cancer
    Qu, Rirong
    Ping, Wei
    Hao, Zhipeng
    Cai, Yixin
    Zhang, Ni
    Fu, Xiangning
    THORACIC CANCER, 2020, 11 (05) : 1319 - 1325
  • [37] Surgical outcomes and complications of pneumonectomy after induction therapy for non-small cell lung cancer
    Kayawake, Hidenao
    Okumura, Norihito
    Yamanashi, Keiji
    Otsuki, Yasuhiro
    Takahashi, Ayuko
    Itasaka, Satoshi
    Yoshioka, Hiroshige
    Nakashima, Takashi
    Matsuoka, Tomoaki
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2018, 66 (11) : 658 - 663
  • [38] Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer
    Carsten Nieder
    Terje Tollåli
    Ellinor Haukland
    Anne Reigstad
    Liv Randi Flatøy
    Kirsten Engljähringer
    Supportive Care in Cancer, 2016, 24 : 4385 - 4391
  • [39] Prognostic Impact of Local Treatment Against Postoperative Oligometastases in Non-Small Cell Lung Cancer
    Yano, Tokujiro
    Haro, Akira
    Yoshida, Tsukihisa
    Morodomi, Yosuke
    Ito, Kensaku
    Shikada, Yasunori
    Shoji, Fumihiro
    Maruyama, Riichiroh
    Maehara, Yoshihiko
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (07) : 852 - 855
  • [40] Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer
    Waqar, Saiama N.
    Waqar, Sadaf H.
    Trinkaus, Kathryn
    Gadea, Carlos A.
    Robinson, Cliff G.
    Bradley, Jeffrey
    Watson, Mark A.
    Puri, Varun
    Govindan, Ramaswamy
    Morgensztern, Daniel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 36 - 40